The UK’s FTSE 100 experienced a decline on Thursday as investors contended with escalating tensions in the Middle East. This downward movement was exacerbated by AstraZeneca, which reported unsatisfactory results from a late-stage trial, contributing to the overall market pressure. The blue-chip FTSE 100 index fell 0.6% to 10,417.63 points by 1045, while the midcap Read More